BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26195590)

  • 1. Novel cell-penetrating peptide targeting mitochondria.
    Cerrato CP; Pirisinu M; Vlachos EN; Langel Ü
    FASEB J; 2015 Nov; 29(11):4589-99. PubMed ID: 26195590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptides induce apoptosis and necrosis through specific mechanism and cause impairment of Na
    Qiu Y; Yu Q; Shi K; Zhang M; Zhou X; Yang Y; Liu Y; Tang J; Wang X; He Q
    Amino Acids; 2017 Jan; 49(1):75-88. PubMed ID: 27645217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.
    Lin R; Zhang P; Cheetham AG; Walston J; Abadir P; Cui H
    Bioconjug Chem; 2015 Jan; 26(1):71-7. PubMed ID: 25547808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Peptidic Cell-Penetrating Motifs for Mitochondrion-Specific Cargo Delivery.
    Appiah Kubi G; Qian Z; Amiar S; Sahni A; Stahelin RV; Pei D
    Angew Chem Int Ed Engl; 2018 Dec; 57(52):17183-17188. PubMed ID: 30376611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial transit peptide exhibits cell penetration ability and efficiently delivers macromolecules to mitochondria.
    Jain A; Chugh A
    FEBS Lett; 2016 Sep; 590(17):2896-905. PubMed ID: 27461847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines.
    Zhao K; Luo G; Giannelli S; Szeto HH
    Biochem Pharmacol; 2005 Dec; 70(12):1796-806. PubMed ID: 16216225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of mitochondrial activity in HaCaT keratinocytes by the cell penetrating peptide Z-Gly-RGD(DPhe)-mitoparan.
    Richardson A; Muir L; Mousdell S; Sexton D; Jones S; Howl J; Ross K
    BMC Res Notes; 2018 Jan; 11(1):82. PubMed ID: 29378648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
    Young Kim H; Young Yum S; Jang G; Ahn DR
    Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-bridged dinuclear Ru(II) complex for mitochondrial targeted monitoring of dynamic changes to oxygen concentration and ROS generation in live mammalian cells.
    Martin A; Byrne A; Burke CS; Forster RJ; Keyes TE
    J Am Chem Soc; 2014 Oct; 136(43):15300-9. PubMed ID: 25265566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
    Kurzawa L; Pellerano M; Morris MC
    Biochim Biophys Acta; 2010 Dec; 1798(12):2274-85. PubMed ID: 20188697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-targeted peptide MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells.
    Chen M; Liu B; Gao Q; Zhuo Y; Ge J
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7027-37. PubMed ID: 21697135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endocytosis on the uptake kinetics of luciferin-conjugated cell-penetrating peptides.
    Mäger I; Langel K; Lehto T; Eiríksdóttir E; Langel U
    Biochim Biophys Acta; 2012 Mar; 1818(3):502-11. PubMed ID: 22155257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.
    Ross MF; Filipovska A; Smith RA; Gait MJ; Murphy MP
    Biochem J; 2004 Nov; 383(Pt. 3):457-68. PubMed ID: 15270716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial properties of Latarcin 1 derived cell-penetrating peptides.
    Budagavi DP; Chugh A
    Eur J Pharm Sci; 2018 Mar; 115():43-49. PubMed ID: 29329747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-targeted antioxidant peptides.
    Rocha M; Hernandez-Mijares A; Garcia-Malpartida K; Bañuls C; Bellod L; Victor VM
    Curr Pharm Des; 2010; 16(28):3124-31. PubMed ID: 20687871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptide exploited syndecans.
    Letoha T; Keller-Pintér A; Kusz E; Kolozsi C; Bozsó Z; Tóth G; Vizler C; Oláh Z; Szilák L
    Biochim Biophys Acta; 2010 Dec; 1798(12):2258-65. PubMed ID: 20138023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.